IBDEI0K8 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9551,0)
 ;;=340.^^41^540^3
 ;;^UTILITY(U,$J,358.3,9551,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9551,1,3,0)
 ;;=3^MULTIPLE SCLEROSIS
 ;;^UTILITY(U,$J,358.3,9551,1,4,0)
 ;;=4^340.
 ;;^UTILITY(U,$J,358.3,9551,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,9552,0)
 ;;=369.4^^41^541^2
 ;;^UTILITY(U,$J,358.3,9552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9552,1,3,0)
 ;;=3^LEGAL BLINDNESS-USA DEF
 ;;^UTILITY(U,$J,358.3,9552,1,4,0)
 ;;=4^369.4
 ;;^UTILITY(U,$J,358.3,9552,2)
 ;;=^268887
 ;;^UTILITY(U,$J,358.3,9553,0)
 ;;=369.00^^41^541^4
 ;;^UTILITY(U,$J,358.3,9553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9553,1,3,0)
 ;;=3^VISUAL IMPAIRMENT
 ;;^UTILITY(U,$J,358.3,9553,1,4,0)
 ;;=4^369.00
 ;;^UTILITY(U,$J,358.3,9553,2)
 ;;=^15310
 ;;^UTILITY(U,$J,358.3,9554,0)
 ;;=369.10^^41^541^1
 ;;^UTILITY(U,$J,358.3,9554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9554,1,3,0)
 ;;=3^BLINDNESS/LOW VISION
 ;;^UTILITY(U,$J,358.3,9554,1,4,0)
 ;;=4^369.10
 ;;^UTILITY(U,$J,358.3,9554,2)
 ;;=^268870
 ;;^UTILITY(U,$J,358.3,9555,0)
 ;;=369.20^^41^541^3
 ;;^UTILITY(U,$J,358.3,9555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9555,1,3,0)
 ;;=3^LOW VISION,BOTH EYES
 ;;^UTILITY(U,$J,358.3,9555,1,4,0)
 ;;=4^369.20
 ;;^UTILITY(U,$J,358.3,9555,2)
 ;;=^71924
 ;;^UTILITY(U,$J,358.3,9556,0)
 ;;=369.3^^41^541^5
 ;;^UTILITY(U,$J,358.3,9556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9556,1,3,0)
 ;;=3^VISUAL LOSS,BOTH EYES,UNSPEC
 ;;^UTILITY(U,$J,358.3,9556,1,4,0)
 ;;=4^369.3
 ;;^UTILITY(U,$J,358.3,9556,2)
 ;;=^268886
 ;;^UTILITY(U,$J,358.3,9557,0)
 ;;=070.54^^41^542^2
 ;;^UTILITY(U,$J,358.3,9557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9557,1,3,0)
 ;;=3^CHR HEP C W/O COMA
 ;;^UTILITY(U,$J,358.3,9557,1,4,0)
 ;;=4^070.54
 ;;^UTILITY(U,$J,358.3,9557,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,9558,0)
 ;;=070.51^^41^542^1
 ;;^UTILITY(U,$J,358.3,9558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9558,1,3,0)
 ;;=3^ACUTE HEP C W/O COMA
 ;;^UTILITY(U,$J,358.3,9558,1,4,0)
 ;;=4^070.51
 ;;^UTILITY(U,$J,358.3,9558,2)
 ;;=^331778
 ;;^UTILITY(U,$J,358.3,9559,0)
 ;;=V02.62^^41^542^3
 ;;^UTILITY(U,$J,358.3,9559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9559,1,3,0)
 ;;=3^HEPATITIS C CARRIER
 ;;^UTILITY(U,$J,358.3,9559,1,4,0)
 ;;=4^V02.62
 ;;^UTILITY(U,$J,358.3,9559,2)
 ;;=^317947
 ;;^UTILITY(U,$J,358.3,9560,0)
 ;;=438.11^^41^543^1
 ;;^UTILITY(U,$J,358.3,9560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9560,1,3,0)
 ;;=3^APHASIA
 ;;^UTILITY(U,$J,358.3,9560,1,4,0)
 ;;=4^438.11
 ;;^UTILITY(U,$J,358.3,9560,2)
 ;;=^317907
 ;;^UTILITY(U,$J,358.3,9561,0)
 ;;=438.13^^41^543^2
 ;;^UTILITY(U,$J,358.3,9561,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9561,1,3,0)
 ;;=3^DYSARTHRIA
 ;;^UTILITY(U,$J,358.3,9561,1,4,0)
 ;;=4^438.13
 ;;^UTILITY(U,$J,358.3,9561,2)
 ;;=^338239
 ;;^UTILITY(U,$J,358.3,9562,0)
 ;;=438.82^^41^543^3
 ;;^UTILITY(U,$J,358.3,9562,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9562,1,3,0)
 ;;=3^DYSPHAGIA
 ;;^UTILITY(U,$J,358.3,9562,1,4,0)
 ;;=4^438.82
 ;;^UTILITY(U,$J,358.3,9562,2)
 ;;=^317923
 ;;^UTILITY(U,$J,358.3,9563,0)
 ;;=438.20^^41^543^4
 ;;^UTILITY(U,$J,358.3,9563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9563,1,3,0)
 ;;=3^HEMIPLEGIA
 ;;^UTILITY(U,$J,358.3,9563,1,4,0)
 ;;=4^438.20
 ;;^UTILITY(U,$J,358.3,9563,2)
 ;;=^317910
 ;;^UTILITY(U,$J,358.3,9564,0)
 ;;=99201^^42^544^1
 ;;^UTILITY(U,$J,358.3,9564,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,9564,1,1,0)
 ;;=1^Problem Focus
 ;;^UTILITY(U,$J,358.3,9564,1,2,0)
 ;;=2^99201
 ;;^UTILITY(U,$J,358.3,9565,0)
 ;;=99202^^42^544^2
 ;;^UTILITY(U,$J,358.3,9565,1,0)
 ;;=^358.31IA^2^2
 ;;
 ;;$END ROU IBDEI0K8
